Direct Coombs Test – DCT

The Direct Coombs Test DCT is a specialized blood test used to identify autoimmune hemolytic anemia which reveals when the immune system attacks red blood cells. This test detects antibodies or complement proteins bound to the surface of red blood cells which lead to anaemia and related symptoms.

Purpose of Direct Coombs Test (DCT)

This test helps:

• Diagnose autoimmune hemolytic anemia
• Monitor the progression of lupus and specific anemic conditions.
• This test is used to identify hemolytic disease of the newborn (HDN)
• Evaluates both organ transplants compatibility and the reactions that occur during blood transfusions.

A positive result of the DCT test indicates that your immune system is targeting red blood cells resulting in symptoms including:

• Fatigue
• Pale skin
• Shortness of breath
• Jaundice (especially in newborns)

Health experts frequently suggest the Direct Coombs Test – DCT for these purposes:

• Newborn babies with jaundice or anemia
• Patients showing symptoms of unexplained hemolysis
• People facing symptoms of immune-related blood disorders

Direct Coombs Test – DCT functions as an essential diagnostic tool for managing autoimmune disorders and neonatal health conditions.

Schedule your test today at UniQ Pathlab with the benefit of free home sample collection, accurate reporting, and specialist analysis to ensure timely and effective medical care.